Pancreatic Cancer Screening Programs
Resources for Familial and Early Detection Screening
Indiana University School of Medicine
975 W. Walnut Street, #130
Indianapolis, IN 46202
Pancreatic Cyst and Cancer Early Detection Center
The mission of the center is to promote early detection and prevent pancreatic cancer through multidisciplinary screening clinics, registries, community outreach, education and research discovery. The roster serves as a resource for researchers studying the causes of pancreatic cancer as well as researchers studying screening methods for pancreatic cancer. Individuals in the roster are eligible for pancreatic cancer research studies conducted at Indiana University or at other academic centers in the United States.
Dr. C. Max Schmidt
Johns Hopkins Hospital
1550 Orleans Street, CRB II
Baltimore, MD 21231
The Sol Goldman Pancreatic Cancer Research Center
National Familial Pancreas Tumor Registry - The registry has led the way in demonstrating that pancreatic cancer does cluster in families and that there is likely to be a genetic cause of this clustering. This work has demonstrated that individuals from familial pancreatic cancer families have a nine-fold increased risk of developing pancreatic cancer.
Dr. Alison P. Klein
Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York, NY 10065
Pancreatic Cancer Tumor Registry - A unique research initiative called the Pancreatic Tumor Registry looks for causes of pancreatic cancer in people with a family history of the disease. Data from the registry will also help to determine whether screening for pancreatic cancer in healthy people with a strong family history of pancreatic cancer is useful.
Dr. Robert C. Kurtz, Principal Investigator
Pamela Nunes, Research Study Assistant
University of Virginia Health System
1215 Lee Street
Charlottesville, VA 22903
Columbia University Medical Center
177 Fort Washington Ave.
New York, NY 10032
Muzzi Mirza Pancreatic Cancer Prevention and Genetics Program - a program focused on prevention techniques and the role of genetics as it relates to the development of pancreatic cancer.
Pancreatic Cyst Surveillance Program - A unique clinic specifically focused on managing pancreatic cysts so that they do not develop into cancer.
Donald Garmon, NP
Tamas A. Gonda, MD
Frank G. Gress, MD
Beth Schrope, MD
University of California - San Francisco
Helen Diller Family Comprehensive Cancer Center
1825 4th Street, Fourth Floor
San Francisco, CA 94158
Pancreas Cancer Research Program - The program conducts large population-based, case-control studies of pancreatic cancer. Its researchers in Epidemiology and Biostatistics lead laboratory and clinic-based studies of the molecular epidemiology of pancreatic cancer.
University of Pennsylvania
Abramson Cancer Center
3535 Market Street, Suite 750
Philadelphia, PA 19104
Gastrointestinal Cancer Risk Evaluation Program - nationally recognized for their expertise in cancer and genetics and can provide information, care and support to help patients throughout the entire risk evaluation program.
Oncology & Hematology of White Plains,
White Plains Hospital Center for Cancer Care
#2 Longview Avenue
White Plains, NY 10601
This program uses a risk of about 5x the general population (or about 7.5% lifetime risk) as their definition for elevated risk, whether it be family history, genetic mutations, or other medical conditions.
Clinical Research Coordinator
Winthrop University Hospital Pancreatic Health Program
120 Mineola Blvd., Suite 320
Mineola, NY 11501
157 E. Woodside Avenue
Patchogue, NY 11772
Two full time geneticists work with the medical faculty to identify patients at high risk for developing pancreatic cancer. Within the high risk registry, patients are screened for precursors of pancreatic cancer with the aim of preventing the disease before it develops.
Dr. John D. Allendorf
Barbara Moskowitz, NP